Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Bastard

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The Cochrane Database of Systematic Reviews|August 23, 2024
Diabetes as a risk factor for tuberculosis diseaseJuan Va Franco, Brenda Bongaerts, Maria-Inti Metzendorf, et al.
The Cochrane Database of Systematic Reviews|June 11, 2024
Undernutrition as a risk factor for tuberculosis diseaseJuan Va Franco, Brenda Bongaerts, Maria-Inti Metzendorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2025
Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modellingStephanie Law, Isabel Fulcher, Samreen Ashraf, et al.
American Journal of Epidemiology|February 2, 2026
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherenceAllison LaHood, James Robins, Helen R Stagg, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
BMJ Open Respiratory Research|December 25, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-upSara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant TuberculosisKwonjune J Seung, Palwasha Khan, Molly F Franke, et al.
Nature Communications|May 9, 2024
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosisSooyeon Kho, Kwonjune J Seung, Helena Huerga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2023
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-upSara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Cochrane Database of Systematic Reviews|August 23, 2024
Diabetes as a risk factor for tuberculosis diseaseJuan Va Franco, Brenda Bongaerts, Maria-Inti Metzendorf, et al.
The Cochrane Database of Systematic Reviews|June 11, 2024
Undernutrition as a risk factor for tuberculosis diseaseJuan Va Franco, Brenda Bongaerts, Maria-Inti Metzendorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2025
Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modellingStephanie Law, Isabel Fulcher, Samreen Ashraf, et al.
American Journal of Epidemiology|February 2, 2026
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherenceAllison LaHood, James Robins, Helen R Stagg, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
BMJ Open Respiratory Research|December 25, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort studyMatthew L Romo, Allison LaHood, Helen R Stagg, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-upSara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant TuberculosisKwonjune J Seung, Palwasha Khan, Molly F Franke, et al.
Nature Communications|May 9, 2024
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosisSooyeon Kho, Kwonjune J Seung, Helena Huerga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2023
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-upSara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Pageof 7